SearcharxivSearch

arXiv subjects

Ananda Shikhara Bhat

Publications and source records attributed to Ananda Shikhara Bhat.

3 recordsLinked to original sources

Demographic senescence as multi-level selection in miniature

Multi-level selection and senescence do not at first sight have much in common. Here, we demonstrate that the emergent mortality patterns generated by demographic senescence can be understood as the product of multi-level selection. We formulate a two-level Moran type process and use its scaling limits to illustrate that a simple mathematical framework that models multi-level selection in group-structured populations also models damage accumulation patterns and resultant mortality curves in ageing organisms. To verbally make the connection, observe that defectors spread within a group consisting of cooperators and defectors; when groups compete against each other, defector-rich groups suffer, and between-group selection causes such groups to be systematically under-represented. Exactly analogously, senescing individuals accumulate damage to physiological sub-systems, and `damage begets damage'; individuals who are more damaged are more likely to die, hence damage-rich individuals are systematically under-represented in later age classes. Thus, emergent senescence patterns in complex, integrated organisms are formally equivalent to the patterns generated by a within-generation multi-level selection process in which intra-organismal sub-systems play the role of particles, organisms play the role of collectives, and selective disappearance plays the role of group selection.

q-bio.PE

A stochastic field theory for the evolution of quantitative traits in finite populations

Infinitely many distinct trait values may arise in populations bearing quantitative traits, and modeling their population dynamics is thus a formidable task. While classical models assume fixed or infinite population size, models in which the total population size fluctuates due to demographic noise in births and deaths can behave qualitatively differently from constant or infinite population models due to density-dependent dynamics. In this paper, I present a stochastic field theory for the eco-evolutionary dynamics of finite populations bearing one-dimensional quantitative traits. I derive stochastic field equations that describe the evolution of population densities, trait frequencies, and the mean value of any trait in the population. These equations recover well-known results such as the replicator-mutator equation, Price equation, and gradient dynamics in the infinite population limit. For finite populations, the equations describe the intricate interplay between natural selection, noise-induced selection, eco-evolutionary feedback, and neutral genetic drift in determining evolutionary trajectories. My work uses ideas from statistical physics, calculus of variations, and SPDEs, providing alternative methods that complement the measure-theoretic martingale approach that is more common in the literature.

q-bio.PE

Studying the age of onset and detection of Chronic Myeloid Leukemia using a three-stage stochastic model

Chronic Myeloid Leukemia (CML) is a biphasic malignant clonal disorder that progresses, first with a chronic phase, where the cells have enhanced proliferation only, and then to a blast phase, where the cells have the ability of self-renewal. It is well-recognized that the Philadelphia chromosome (which contains the BCR-ABL fusion gene) is the "hallmark of CML". However, empirical studies have shown that the mere presence of BCR-ABL may not be a sufficient condition for the development of CML, and further modifications related to tumor suppressors may be necessary. Accordingly, we develop a three-mutation stochastic model of CML progression, with the three stages corresponding to the non-malignant cells with BCR-ABL presence, the malignant cells in the chronic phase and the malignant cells in the blast phase. We demonstrate that the model predictions agree with age incidence data from the United States. Finally, we develop a framework for the retrospective estimation of the time of onset of malignancy, from the time of detection of the cancer.

q-bio.QM